share_log

Chief Operating Officer Christian Voigtlander Sold A Bunch Of Shares In ICU Medical

Chief Operating Officer Christian Voigtlander Sold A Bunch Of Shares In ICU Medical

首席运营官克里斯蒂安·沃伊特兰德出售了重症监护病房医疗的大量股份
Simply Wall St ·  03/07 05:57

Some ICU Medical, Inc. (NASDAQ:ICUI) shareholders may be a little concerned to see that the Chief Operating Officer, Christian Voigtlander, recently sold a substantial US$1.5m worth of stock at a price of US$107 per share. Probably the most concerning element of the whole transaction is that the disposal amounted to 100% of their entire holding.

一些ICU Medical, Inc.(纳斯达克股票代码:ICUI)的股东可能会有点担心,首席运营官克里斯蒂安·沃伊特兰德最近以每股107美元的价格出售了价值150万美元的大量股票。整个交易中最令人担忧的因素可能是处置占其全部持股的100%。

ICU Medical Insider Transactions Over The Last Year

去年的重症监护病房医疗内幕交易

Notably, that recent sale by Christian Voigtlander is the biggest insider sale of ICU Medical shares that we've seen in the last year. That means that an insider was selling shares at around the current price of US$104. While we don't usually like to see insider selling, it's more concerning if the sales take place at a lower price. Given that the sale took place at around current prices, it makes us a little cautious but is hardly a major concern.

值得注意的是,克里斯蒂安·沃伊特兰德最近的出售是我们在去年看到的最大规模的ICU Medical股票内幕出售。这意味着一位内部人士正在以目前的104美元左右的价格出售股票。虽然我们通常不喜欢看到内幕销售,但更令人担忧的是是否以较低的价格进行销售。鉴于此次出售是以当前价格进行的,这使我们有点谨慎,但并不是一个主要问题。

ICU Medical insiders didn't buy any shares over the last year. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

去年,ICU Medical的内部人士没有购买任何股票。您可以看到下图所示的去年的内幕交易(公司和个人)。如果你点击图表,你可以看到所有的个人交易,包括股价、个人和日期!

insider-trading-volume
NasdaqGS:ICUI Insider Trading Volume March 7th 2024
纳斯达克GS:ICUI 内幕交易量 2024 年 3 月 7 日

I will like ICU Medical better if I see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

如果我看到一些重大的内幕收购,我会更喜欢ICU Medical。在我们等待的同时,请查看这份免费清单,列出了最近有大量内幕收购的成长型公司。

Does ICU Medical Boast High Insider Ownership?

ICU Medical拥有很高的内部所有权吗?

Many investors like to check how much of a company is owned by insiders. We usually like to see fairly high levels of insider ownership. ICU Medical insiders own about US$152m worth of shares (which is 6.1% of the company). I like to see this level of insider ownership, because it increases the chances that management are thinking about the best interests of shareholders.

许多投资者喜欢查看公司内部人士拥有多少股份。我们通常希望看到相当高的内部所有权水平。ICU Medical内部人士拥有价值约1.52亿美元的股份(占该公司的6.1%)。我喜欢看到这种程度的内部所有权,因为它增加了管理层考虑股东最大利益的机会。

What Might The Insider Transactions At ICU Medical Tell Us?

ICU Medical 的内幕交易可能会告诉我们什么?

An insider sold ICU Medical shares recently, but they didn't buy any. Looking to the last twelve months, our data doesn't show any insider buying. While insiders do own a lot of shares in the company (which is good), our analysis of their transactions doesn't make us feel confident about the company. While we like knowing what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. For example, ICU Medical has 2 warning signs (and 1 which is a bit unpleasant) we think you should know about.

一位内部人士最近出售了ICU Medical的股票,但他们没有购买任何股票。展望过去的十二个月,我们的数据并未显示任何内幕买盘。尽管内部人士确实拥有该公司的大量股份(这很好),但我们对他们交易的分析并不能使我们对公司充满信心。虽然我们喜欢了解内部人士的所有权和交易情况,但在做出任何投资决策之前,我们一定要考虑股票面临的风险。例如,ICU Medical 有 2 个警告信号(以及 1 个有点不愉快),我们认为你应该知道。

But note: ICU Medical may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

但请注意:ICU Medical可能不是最好的买入股票。因此,来看看这份投资回报率高、债务低的有趣公司的免费清单。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

就本文而言,内部人士是指向相关监管机构报告其交易的个人。我们目前只考虑公开市场交易和私下处置的直接利益,不包括衍生品交易或间接权益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发